相关实验视频

Updated: Jan 16, 2026

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

长非编码RNAIGF2-AS在抗他莫西芬乳腺癌细胞中的差异表达

Jeeyeon Lee^1,2, Byeongju Kang^1,2, Eun Ae Kim³

¹Department of Surgery, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.

|September 27, 2025

概括

长非编码RNAIGF2-AS在抗他莫西芬乳腺癌中升高,促进癌细胞的生长和入侵. 这一发现表明IGF2-AS是克服内分泌抵抗的潜在治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

乳腺癌,特别是光线亚型,通常用内分泌疗法治疗.
在20-30%的患者中发展出治疗耐药性,导致侵袭性疾病.
长非编码RNAs (lncRNAs) 越来越多地被认为对癌症进展和治疗耐药性的作用.

研究的目的:

为了研究 lncRNA 胰岛素样生长因子2 抗体 (IGF2-AS) 在抗他莫西芬乳腺癌中的作用.
评估IGF2-AS作为克服他莫西芬耐药性的潜在治疗标.

主要方法:

定量PCR (qPCR) 用于测量IgF2-AS表达在抗他莫西芬 (TAMR-V,TAMR-H) 和控制 (MCF-7) 细胞系中的表达.
通过siRNA介导的IGF2-AS的淘汰,以评估其对细胞增殖,入侵和迁移的影响.
下一代测序 (NGS) 用于差异基因表达分析.
卡普兰-梅尔生存分析以将IGF2-AS表达与患者预后相关联.

主要成果:

与MCF-7细胞相比,IGF2-AS表达在TAMR-V和TAMR-H细胞中显著上调.
IGF2-AS knockdown 抑制了TAMR-V细胞的增殖和入侵,但不是TAMR-H细胞,表明细胞特异性的作用.
NGS揭示了TAMR-V和TAMR-H细胞之间的独特基因表达特征,突出了各种抗性机制.
在多种乳腺癌亚型中,高IGF2-AS表达与较差的患者存活率相关.

结论:

在耐他莫西芬乳腺癌中,IGF2-AS被上调,并以细胞特异的方式促进扩散和入侵.
耐药细胞系中IGF2-AS的差异表达突显了耐药机制的复杂性.
在乳腺癌中,IGF2-AS是一个有前途的治疗标,可以克服对他莫西芬的耐药性.

关键词:

在IGF2-AS中,IGF2-AS是最常见的.乳腺癌乳腺癌乳腺癌在ncRNA中,我们可以电阻的电阻是指电阻的电阻泰莫西芬 (Tamoxifen) 是一种

更多相关视频

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Published on: March 1, 2019

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...